Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Gregory Hinckley
AddedFeb 15, 2024
UpdatedMay 1, 2026
Gregory Hinckley

Gregory Hinckley

Board Member, Bio-Rad

Gregory Hinckley's Career

Bio-Rad
Bio-Rad

Hercules, CA, US

Board Member· Board
ArcSoft
ArcSoft

Fremont, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Gregory Hinckley's Career

Bio-Rad
Bio-Rad
Public$1.2B8k1952Hercules, CA, US
Board Member· Board

Leadership at Bio-Rad

Melinda LitherlandMelinda LitherlandBoard Member
Norman SchwartzNorman SchwartzCEO
Alice SchwartzAlice SchwartzCo-Founder
David SchwartzDavid SchwartzCo-Founder
Mr. David SchwartzMr. David SchwartzBoard Member
Allison SchwartzAllison SchwartzBoard Member

Similar to Bio-Rad

Portal BiotechnologiesPortal BiotechnologiesWatertown, MA, USest. 2023Portal BiotechnologiesWatertown, MA, US · est. 2023

Portal Biotechnologies is a Watertown, Massachusetts-based cell engineering and drug discovery platform company founded in 2023.

Series A · $9M
Harvard BioscienceHarvard BioscienceHolliston, MA, USLife Sciences Equipmentest. 1901Harvard BioscienceHolliston, MA, US · est. 1901

Harvard Bioscience, Inc.: A global developer and supplier of life sciences equipment for research and drug discovery.

Public428
FluidigmFluidigmSouth San Francisco, CA, USBiotechnologyest. 1999FluidigmSouth San Francisco, CA, US · est. 1999

Standard BioTools Inc., based in South San Francisco, accelerates life sciences research with essential, standardized technologies.

Public615
RevvityRevvityWaltham, MA, USLife Science Researchest. 1937RevvityWaltham, MA, US · est. 1937

PerkinElmer: A global leader in diagnostics, life science research, and industrial testing, operating in 190 countries.

Public16.7k
ArcSoft
ArcSoft
Series B$20M8001994Fremont, CA, US
Board Member· Board

Leadership at ArcSoft

David NagelDavid NagelBoard Member
Dan MacKeiganDan MacKeiganBoard Member
Michael DengMichael DengBoard Member
Dr Ronald J Smith \"Ron\"Dr Ronald J Smith \"Ron\"Board Member
Xiangxin BiXiangxin BiBoard Member
Jin WangJin WangBoard Member

Similar to ArcSoft

PicsartPicsartSan Francisco, CA, USPhoto Editingest. 2011PicsartSan Francisco, CA, US · est. 2011

Picsart: A global software company offering innovative photo/video editing apps with a creative community.

Series C · $195M1k
MeituMeituXiamen, Fujian, CNest. 2008MeituXiamen, Fujian, CN · est. 2008

Meitu, Inc.: A global Chinese tech firm specializing in mobile apps for image editing, live broadcasting, and social software.

Public · $501M2.1k
Sound VisionSound VisionFramingham, MA, USSilicon, Softwareest. 1995Sound VisionFramingham, MA, US · est. 1995

Sound Vision develops integrated software and silicon solutions for digital imaging and sensing, catering to various markets.

Public · $21M5
ThunderSoftThunderSoftBeijing, Beijing, CNOperating Systems, Softwareest. 2008ThunderSoftBeijing, Beijing, CN · est. 2008

ThunderSoft, a Beijing-based software company, specializes in OS technologies and intelligent device solutions, with a global presence.

Public · $100M11.5k

Gregory Hinckley's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Gregory Hinckley

Helen LohHelen LohBoard Member · Charles SchwabJohn G. FreundJohn G. FreundAdvisor · Medical Devices CornerBruce StroeverBruce StroeverBoard Member · Bone BiologicsAnthony G. ViscogliosiAnthony G. ViscogliosiBoard Member · Small Bone InnovationsSam RiccitelliSam RiccitelliBoard Member · BioceptWes JohnsonWes JohnsonBoard Member · AngioDynamics